Yogini Jani - Academia.edu (original) (raw)
Papers by Yogini Jani
BMC Palliative Care
Background Children and young people are usually given liquid morphine by mouth for breakthrough ... more Background Children and young people are usually given liquid morphine by mouth for breakthrough pain, which can take thirty minutes to work. A faster-acting, quickly absorbed, needle-free pain medicine, that is easy to administer is needed such as transmucosal (sublingual, buccal, intranasal) diamorphine. Research evidence relating to the administration of medication for breakthrough pain in children and young people is limited. This study aims to describe the experiences and preferences of parents and/or children and young people regarding the route of administration of diamorphine, barriers and facilitators comparative to oral morphine, and participation in a randomised controlled trial. Methods In-depth, semi-structured interviews with parents and/or children and young people at home or hospital/hospice. Results Thirteen interviews with: nine mothers, one father, and three sets of parents jointly. No interviews took place with a child/young person. Most families had experience o...
Background In order to reduce safety risks associated with medication administrations, technologi... more Background In order to reduce safety risks associated with medication administrations, technologies such as barcode medication administration (BCMA) are increasingly used. Examining how human factors influence adoption and usability of this technology can potentially highlight areas for improvement in design and implementation. Objective To describe how human factors related determinants for BCMA have been researched and reported by healthcare and human–computer interaction disciplines. Data sources The Cumulative Index of Nursing, and Allied Health Literature, PubMed, OVID MEDLINE and Google Scholar. Study eligibility criteria Primary research published from April 2000 to April 2020, search terms developed to identity different disciplinary research perspectives that examined BCMA use, used a human factors lens and were published in English. Synthesis methods Computerised systematic searches were conducted in four databases. Eligible papers were systematically analysed for themes. ...
Journal of Critical Care, 2015
PURPOSE. To describe clinical pharmacist interventions across a range of critical care units (CCU... more PURPOSE. To describe clinical pharmacist interventions across a range of critical care units (CCUs) throughout the United Kingdom (UK). To identify CCU medication error rate, prescription optimisation and to identify the type and impact of each intervention in the prevention of harm and improvement of patient therapy. MATERIALS AND METHODS. A prospective observational study was undertaken in 21 UK CCUs from 5-18 th Nov 2012. A data collection web portal was designed where the specialist critical care pharmacist (SCCP) reported all interventions at their site. Each intervention was classified as either: medication error, optimisation or consult. In addition, a clinical impact scale was used to code the interventions. Interventions were scored as low, moderate, high impact and life saving. The final coding was moderated by blinded independent multidisciplinary trialists. RESULTS. 20,517 prescriptions were reviewed with 3,294 interventions recorded during the weekdays. This resulted in an overall intervention rate of 16.1%: 6.8% were classified as medication errors, 8.3 % optimisations and 1.0% consults. The interventions were classified as: low impact (34.0%), moderate impact (46.7%) high impact (19.3%) and one case was life saving. Almost three-quarters of interventions were to optimise the effectiveness of and improve safety of pharmacotherapy. CONCLUSIONS. This observational study demonstrated that both medication error resolution and pharmacist led optimisation rates were substantial. Almost 1 in 6 prescriptions required an intervention from the clinical pharmacist. The error rate was slightly lower than an earlier UK prescribing error study (EQUIP). Two thirds of the interventions were of moderate to high impact.
... Office noted that the direct financial cost of NHS medicines wastage in England as defined in... more ... Office noted that the direct financial cost of NHS medicines wastage in England as defined in this manner (calculated in list price terms, and including not only unused drugs but also items such as surplus dressings, appliances and prescribed nutritional supplements like 'sip ...
Additional file 1. Interview guide and vignettes.
Interview guide- Multiple EP systems study. A list of the questions and prompts used in the inter... more Interview guide- Multiple EP systems study. A list of the questions and prompts used in the interviews conducted in the study. (DOCX 17 kb)
List of assumptions used to determine potential likelihood of interactions/ overlap between syste... more List of assumptions used to determine potential likelihood of interactions/ overlap between systems. A series of assumptions utilised to determine the Likelihood of systems overlap which was used in the decision matrix created aiming to achieve a maximum variation sample. (DOCX 14 kb)
This large scale evaluation would not have been possible without the help of a number of people w... more This large scale evaluation would not have been possible without the help of a number of people who we here take great pleasure in acknowledging. First and foremost, we thank the participating NHS Trusts and individual participants for their time and support.
Cancer Medicine, 2021
BACKGROUND Re-designing services and processes to meet growing demands in chemotherapy services i... more BACKGROUND Re-designing services and processes to meet growing demands in chemotherapy services is necessary with increasing treatments. There is little evidence guiding the timing and thresholds to be attained of pre-chemotherapy blood assessments, namely neutrophils. METHODS A survey was developed and distributed to health professionals in the United Kingdom (UK) to examine current practice in timing and threshold values of neutrophils and platelets before treatment administration. This was followed by a retrospective cohort study, using data from electronic patient record systems; including patients initiating treatment between January 2013 and December 2018, to determine a safe timeframe for blood assessments; comparing neutrophil, platelet, creatinine and bilirubin levels at different time points. RESULTS The survey captured 25% of hospitals in the UK and variations were apparent in both the timing of assessments and thresholds needed, particularly for neutrophils. 616 (6.5%) of 4007 patients included had neutrophil levels measured twice within 7 days of treatment (with the first level taken beyond 3 days and the second test being within 3 days of treatment- the UK standard). Of the patients that attained an acceptable neutrophil level at their first test, five of the 616 (0.8%) became ineligible for administration from the test 2 level. 23% of patients improved their grade and became eligible for treatment. Little difference was observed for platelets. CONCLUSIONS We have demonstrated that extending the timeframe for blood tests can be safe, however, this practice may cause unnecessary delays for patients if only an early test is relied on for eligibility.
Archives of Asthma, Allergy and Immunology, 2017
Prevalence of reported drug allergy and its impact on Beta lactam use with fi nancial and health ... more Prevalence of reported drug allergy and its impact on Beta lactam use with fi nancial and health implications Abirami Murugesh-Warren1,2,#, Ranu Malhi1,3,#, Yogini Jani1, Christopher Corrigan4, David Walker1, Harsha Kariyawasam1 and Joanna Lukawska1,4* 1University College London Hospitals, 235 Euston Rd, Bloomsbury, London NW1 2BU, UK 2Whittington Hospital NHS Trust, Magdala Ave, London N19 5NF, UK 3McMaster Children’s Hospital, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada 4King’s College London, Guy’s Hospital, London SE1 9RT, UK
Pediatric Nephrology, 2014
Background Medication-related problems (MRPs) are the undesirable effects of pharmacotherapy that... more Background Medication-related problems (MRPs) are the undesirable effects of pharmacotherapy that can potentially lead to harm. The epidemiology of MRPs in paediatric renal patients is unknown. We aimed to characterise MRPs in this population at two tertiary care hospitals in the UK. Methods Prescription charts for children (≤18 years) were reviewed to identify MRPs, and characterised using a specific proforma with a standard operational definition. MRP predictors were evaluated by logistic regression and severity was assessed using a validated scale. Results Two hundred and sixty-seven MRPs were identified from 266 prescription chart reviews. The incidence was 51.2 % (203 MRPs, 166 charts; 95 % CI 43.2-60.6 %) of hospitalised patients and 32 % (64 MRPs, 100 charts; 95 % CI 22.9-41.1 %) in outpatients. The number of prescribed medications was the only independent predictor during inpatient treatment (OR 1.06, 95 % CI 1.02-1.10, p=0.002) with no significant predictors identified at outpatient clinics. The severity level of the MRPs was minor: 53.9 %, (144 out of 267); or moderate: 46.1 %, (123 out of 267). Sub-optimal drug effect was the predominant MRP (inpatient: 68 %; outpatient: 39 %). Prescribing error and patients' medicine-taking behaviour were the main contributory factors. The majority of the MRPs in the inpatient setting were resolved. Conclusion Many factors are associated with MRPs in children; the associations are cumulative and interdependent. Investment in preventive strategies and extending the support from the acute health care setting into the community are invaluable for optimising pharmacotherapy.
BMJ Quality & Safety, 2021
Antimicrobial resistance (AMR) is a significant problem in global health today, particularly in L... more Antimicrobial resistance (AMR) is a significant problem in global health today, particularly in Low- and Middle-Income Countries (LMICs) where antimicrobial stewardship programmes are yet to be successfully implemented. We established a partnership between AMR pharmacists leads from a UK NHS hospital and in Ho Teaching Hospital with the aim to by enhance antimicrobial stewardship knowledge and practice among healthcare providers through an educational intervention. We employed a mixed method approach including an initial before and after training survey on knowledge and awareness, followed by qualitative interviews with healthcare providers conducted six months after delivery of training. This study was carried out in Ho teaching hospital with 18 healthcare professionals including pharmacists, medical doctors, nurses and medical laboratory scientists. Ethical approval was obtained prior to data collection. In the first phase, we surveyed 50 health care providers including nurses (33...
Quality issue: Approximately 10% of patients are harmed by healthcare, and of this harm 15% is th... more Quality issue: Approximately 10% of patients are harmed by healthcare, and of this harm 15% is thought to be medication related. Despite this, medication safety data used for improvement purposes are not often routinely collected by healthcare organizations over time. Initial assessment: A need for a prospective medication safety measurement tool was identified. Choice of solution: The aim was to develop a tool to allow measurement and aid improvement of medication safety over time. The methodology used for the National Health Service (NHS) Safety Thermometer was identified as an approach. The resulting tool was named the ‘Medication Safety Thermometer’. Implementation: The development of the Medication Safety Thermometer was facilitated by a multidisciplinary steering group using a Plan, Do, Study, Act (PDSA) method. Alpha and beta testing occurred over a period of 9 months. The tool was officially launched in October 2013 and continued to be improved until May 2016 using ongoing u...
The Pharmaceutical Journal, 2005
Results Before supplementary prescribing, 88 prescriptions (53.7%) were in accordance with the gu... more Results Before supplementary prescribing, 88 prescriptions (53.7%) were in accordance with the guidelines. After supplementary prescribing was introduced, the doctors’ levels of compliance with the guidelines did not significantly change but all of the 26 prescriptions (100%) issued by the pharmacist supplementary prescriber were appropriate, representing a statistically significant difference (P<0.001).
Aim/Objective: To determine the potential risk factors for the occurrence of drug—related problem... more Aim/Objective: To determine the potential risk factors for the occurrence of drug—related problems (DRPs) in hospitalised paediatric nephrology patients. Methods: A prospective cohort study conducted in two paediatric nephrology wards over a ten-month period from December 2011 to September 2012. Inclusion criteria were all children aged 18 years and younger, received at least one drug throughout hospitalisation and given for more than 24 hours. DRPs were identifi ed by clinical pharmacists during ward rounds and discussion with the medical team. Patients’ characteristics and the nature of DRPs were documented into a specifi c proforma. The risk factors were tested for age, gender, length of hospital stay, number of drugs prescribed and types of renal replacement therapy using multivariate logistic regression at patient level. A p values less than 0.05 were considered statistically signifi cant. Results: A total of 171 patients were recruited of which 132 were included in the analysi...
A standardised Global Point Prevalence Survey (PPS) tool was used to determine the antimicrobial ... more A standardised Global Point Prevalence Survey (PPS) tool was used to determine the antimicrobial prescription pattern in the Ho Teaching Hospital on two separate occasions in a total of 14 wards in the hospital, including dedicated wards for paediatrics and neonates. Manually collected and anonymised data were entered, validated, analysed and reported using a web-based global PPS application. With 147 and 153 patients considered in the July 2019 and January 2020 surveys, respectively, 98 patients (66.7%) and 84 patients (54.9%) had received one or more antimicrobials. The prevalence of antimicrobial use in the adult wards was 64.3% (72/112) and 53.4% (63/118) in the first and second surveys, respectively. The prevalence in the paediatric wards was 60.0% (12/20) and 62.5% (10/16), respectively, in the two surveys, while that in the neonatal wards was 93.3% (14/15) and 57.9% (11/19), respectively. β-lactams were the most used antibiotics in both periods. Malaria was the most common di...
Information resource commissioned by NHS CFH to support the implementation of ePrescribing within... more Information resource commissioned by NHS CFH to support the implementation of ePrescribing within acute and foundation trusts. Aimed at senior decision makers within trusts, but also colleagues – including practising clinicians – who may be implementing, supporting and/or using ePrescribing systems.
Objectives The medication safety officer (MSO) role was created following a patient safety alert,... more Objectives The medication safety officer (MSO) role was created following a patient safety alert, with an action for MSOs to be active participants in a national network in England, which included regular online webinar meetings and an online forum. The aim of the study was to assess the effectiveness of digital platforms in facilitating interaction and communication by the MSO network. The objectives were to establish the proportion of MSOs who interact through monthly webinars and the online forum. A secondary objective was to identify barriers and facilitators for engaging digitally within the MSO network. Methods An online survey was used alongside semistructured interviews. The online survey was disseminated to all 400 MSOs registered with the UK Department of Health Central Alerting System from December 2018 to February 2019. Interviewees were identified purposively through snowball sampling and voluntarily through the survey. Results 84 MSOs responded to the survey (21% respo...
BMC Palliative Care
Background Children and young people are usually given liquid morphine by mouth for breakthrough ... more Background Children and young people are usually given liquid morphine by mouth for breakthrough pain, which can take thirty minutes to work. A faster-acting, quickly absorbed, needle-free pain medicine, that is easy to administer is needed such as transmucosal (sublingual, buccal, intranasal) diamorphine. Research evidence relating to the administration of medication for breakthrough pain in children and young people is limited. This study aims to describe the experiences and preferences of parents and/or children and young people regarding the route of administration of diamorphine, barriers and facilitators comparative to oral morphine, and participation in a randomised controlled trial. Methods In-depth, semi-structured interviews with parents and/or children and young people at home or hospital/hospice. Results Thirteen interviews with: nine mothers, one father, and three sets of parents jointly. No interviews took place with a child/young person. Most families had experience o...
Background In order to reduce safety risks associated with medication administrations, technologi... more Background In order to reduce safety risks associated with medication administrations, technologies such as barcode medication administration (BCMA) are increasingly used. Examining how human factors influence adoption and usability of this technology can potentially highlight areas for improvement in design and implementation. Objective To describe how human factors related determinants for BCMA have been researched and reported by healthcare and human–computer interaction disciplines. Data sources The Cumulative Index of Nursing, and Allied Health Literature, PubMed, OVID MEDLINE and Google Scholar. Study eligibility criteria Primary research published from April 2000 to April 2020, search terms developed to identity different disciplinary research perspectives that examined BCMA use, used a human factors lens and were published in English. Synthesis methods Computerised systematic searches were conducted in four databases. Eligible papers were systematically analysed for themes. ...
Journal of Critical Care, 2015
PURPOSE. To describe clinical pharmacist interventions across a range of critical care units (CCU... more PURPOSE. To describe clinical pharmacist interventions across a range of critical care units (CCUs) throughout the United Kingdom (UK). To identify CCU medication error rate, prescription optimisation and to identify the type and impact of each intervention in the prevention of harm and improvement of patient therapy. MATERIALS AND METHODS. A prospective observational study was undertaken in 21 UK CCUs from 5-18 th Nov 2012. A data collection web portal was designed where the specialist critical care pharmacist (SCCP) reported all interventions at their site. Each intervention was classified as either: medication error, optimisation or consult. In addition, a clinical impact scale was used to code the interventions. Interventions were scored as low, moderate, high impact and life saving. The final coding was moderated by blinded independent multidisciplinary trialists. RESULTS. 20,517 prescriptions were reviewed with 3,294 interventions recorded during the weekdays. This resulted in an overall intervention rate of 16.1%: 6.8% were classified as medication errors, 8.3 % optimisations and 1.0% consults. The interventions were classified as: low impact (34.0%), moderate impact (46.7%) high impact (19.3%) and one case was life saving. Almost three-quarters of interventions were to optimise the effectiveness of and improve safety of pharmacotherapy. CONCLUSIONS. This observational study demonstrated that both medication error resolution and pharmacist led optimisation rates were substantial. Almost 1 in 6 prescriptions required an intervention from the clinical pharmacist. The error rate was slightly lower than an earlier UK prescribing error study (EQUIP). Two thirds of the interventions were of moderate to high impact.
... Office noted that the direct financial cost of NHS medicines wastage in England as defined in... more ... Office noted that the direct financial cost of NHS medicines wastage in England as defined in this manner (calculated in list price terms, and including not only unused drugs but also items such as surplus dressings, appliances and prescribed nutritional supplements like 'sip ...
Additional file 1. Interview guide and vignettes.
Interview guide- Multiple EP systems study. A list of the questions and prompts used in the inter... more Interview guide- Multiple EP systems study. A list of the questions and prompts used in the interviews conducted in the study. (DOCX 17 kb)
List of assumptions used to determine potential likelihood of interactions/ overlap between syste... more List of assumptions used to determine potential likelihood of interactions/ overlap between systems. A series of assumptions utilised to determine the Likelihood of systems overlap which was used in the decision matrix created aiming to achieve a maximum variation sample. (DOCX 14 kb)
This large scale evaluation would not have been possible without the help of a number of people w... more This large scale evaluation would not have been possible without the help of a number of people who we here take great pleasure in acknowledging. First and foremost, we thank the participating NHS Trusts and individual participants for their time and support.
Cancer Medicine, 2021
BACKGROUND Re-designing services and processes to meet growing demands in chemotherapy services i... more BACKGROUND Re-designing services and processes to meet growing demands in chemotherapy services is necessary with increasing treatments. There is little evidence guiding the timing and thresholds to be attained of pre-chemotherapy blood assessments, namely neutrophils. METHODS A survey was developed and distributed to health professionals in the United Kingdom (UK) to examine current practice in timing and threshold values of neutrophils and platelets before treatment administration. This was followed by a retrospective cohort study, using data from electronic patient record systems; including patients initiating treatment between January 2013 and December 2018, to determine a safe timeframe for blood assessments; comparing neutrophil, platelet, creatinine and bilirubin levels at different time points. RESULTS The survey captured 25% of hospitals in the UK and variations were apparent in both the timing of assessments and thresholds needed, particularly for neutrophils. 616 (6.5%) of 4007 patients included had neutrophil levels measured twice within 7 days of treatment (with the first level taken beyond 3 days and the second test being within 3 days of treatment- the UK standard). Of the patients that attained an acceptable neutrophil level at their first test, five of the 616 (0.8%) became ineligible for administration from the test 2 level. 23% of patients improved their grade and became eligible for treatment. Little difference was observed for platelets. CONCLUSIONS We have demonstrated that extending the timeframe for blood tests can be safe, however, this practice may cause unnecessary delays for patients if only an early test is relied on for eligibility.
Archives of Asthma, Allergy and Immunology, 2017
Prevalence of reported drug allergy and its impact on Beta lactam use with fi nancial and health ... more Prevalence of reported drug allergy and its impact on Beta lactam use with fi nancial and health implications Abirami Murugesh-Warren1,2,#, Ranu Malhi1,3,#, Yogini Jani1, Christopher Corrigan4, David Walker1, Harsha Kariyawasam1 and Joanna Lukawska1,4* 1University College London Hospitals, 235 Euston Rd, Bloomsbury, London NW1 2BU, UK 2Whittington Hospital NHS Trust, Magdala Ave, London N19 5NF, UK 3McMaster Children’s Hospital, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada 4King’s College London, Guy’s Hospital, London SE1 9RT, UK
Pediatric Nephrology, 2014
Background Medication-related problems (MRPs) are the undesirable effects of pharmacotherapy that... more Background Medication-related problems (MRPs) are the undesirable effects of pharmacotherapy that can potentially lead to harm. The epidemiology of MRPs in paediatric renal patients is unknown. We aimed to characterise MRPs in this population at two tertiary care hospitals in the UK. Methods Prescription charts for children (≤18 years) were reviewed to identify MRPs, and characterised using a specific proforma with a standard operational definition. MRP predictors were evaluated by logistic regression and severity was assessed using a validated scale. Results Two hundred and sixty-seven MRPs were identified from 266 prescription chart reviews. The incidence was 51.2 % (203 MRPs, 166 charts; 95 % CI 43.2-60.6 %) of hospitalised patients and 32 % (64 MRPs, 100 charts; 95 % CI 22.9-41.1 %) in outpatients. The number of prescribed medications was the only independent predictor during inpatient treatment (OR 1.06, 95 % CI 1.02-1.10, p=0.002) with no significant predictors identified at outpatient clinics. The severity level of the MRPs was minor: 53.9 %, (144 out of 267); or moderate: 46.1 %, (123 out of 267). Sub-optimal drug effect was the predominant MRP (inpatient: 68 %; outpatient: 39 %). Prescribing error and patients' medicine-taking behaviour were the main contributory factors. The majority of the MRPs in the inpatient setting were resolved. Conclusion Many factors are associated with MRPs in children; the associations are cumulative and interdependent. Investment in preventive strategies and extending the support from the acute health care setting into the community are invaluable for optimising pharmacotherapy.
BMJ Quality & Safety, 2021
Antimicrobial resistance (AMR) is a significant problem in global health today, particularly in L... more Antimicrobial resistance (AMR) is a significant problem in global health today, particularly in Low- and Middle-Income Countries (LMICs) where antimicrobial stewardship programmes are yet to be successfully implemented. We established a partnership between AMR pharmacists leads from a UK NHS hospital and in Ho Teaching Hospital with the aim to by enhance antimicrobial stewardship knowledge and practice among healthcare providers through an educational intervention. We employed a mixed method approach including an initial before and after training survey on knowledge and awareness, followed by qualitative interviews with healthcare providers conducted six months after delivery of training. This study was carried out in Ho teaching hospital with 18 healthcare professionals including pharmacists, medical doctors, nurses and medical laboratory scientists. Ethical approval was obtained prior to data collection. In the first phase, we surveyed 50 health care providers including nurses (33...
Quality issue: Approximately 10% of patients are harmed by healthcare, and of this harm 15% is th... more Quality issue: Approximately 10% of patients are harmed by healthcare, and of this harm 15% is thought to be medication related. Despite this, medication safety data used for improvement purposes are not often routinely collected by healthcare organizations over time. Initial assessment: A need for a prospective medication safety measurement tool was identified. Choice of solution: The aim was to develop a tool to allow measurement and aid improvement of medication safety over time. The methodology used for the National Health Service (NHS) Safety Thermometer was identified as an approach. The resulting tool was named the ‘Medication Safety Thermometer’. Implementation: The development of the Medication Safety Thermometer was facilitated by a multidisciplinary steering group using a Plan, Do, Study, Act (PDSA) method. Alpha and beta testing occurred over a period of 9 months. The tool was officially launched in October 2013 and continued to be improved until May 2016 using ongoing u...
The Pharmaceutical Journal, 2005
Results Before supplementary prescribing, 88 prescriptions (53.7%) were in accordance with the gu... more Results Before supplementary prescribing, 88 prescriptions (53.7%) were in accordance with the guidelines. After supplementary prescribing was introduced, the doctors’ levels of compliance with the guidelines did not significantly change but all of the 26 prescriptions (100%) issued by the pharmacist supplementary prescriber were appropriate, representing a statistically significant difference (P<0.001).
Aim/Objective: To determine the potential risk factors for the occurrence of drug—related problem... more Aim/Objective: To determine the potential risk factors for the occurrence of drug—related problems (DRPs) in hospitalised paediatric nephrology patients. Methods: A prospective cohort study conducted in two paediatric nephrology wards over a ten-month period from December 2011 to September 2012. Inclusion criteria were all children aged 18 years and younger, received at least one drug throughout hospitalisation and given for more than 24 hours. DRPs were identifi ed by clinical pharmacists during ward rounds and discussion with the medical team. Patients’ characteristics and the nature of DRPs were documented into a specifi c proforma. The risk factors were tested for age, gender, length of hospital stay, number of drugs prescribed and types of renal replacement therapy using multivariate logistic regression at patient level. A p values less than 0.05 were considered statistically signifi cant. Results: A total of 171 patients were recruited of which 132 were included in the analysi...
A standardised Global Point Prevalence Survey (PPS) tool was used to determine the antimicrobial ... more A standardised Global Point Prevalence Survey (PPS) tool was used to determine the antimicrobial prescription pattern in the Ho Teaching Hospital on two separate occasions in a total of 14 wards in the hospital, including dedicated wards for paediatrics and neonates. Manually collected and anonymised data were entered, validated, analysed and reported using a web-based global PPS application. With 147 and 153 patients considered in the July 2019 and January 2020 surveys, respectively, 98 patients (66.7%) and 84 patients (54.9%) had received one or more antimicrobials. The prevalence of antimicrobial use in the adult wards was 64.3% (72/112) and 53.4% (63/118) in the first and second surveys, respectively. The prevalence in the paediatric wards was 60.0% (12/20) and 62.5% (10/16), respectively, in the two surveys, while that in the neonatal wards was 93.3% (14/15) and 57.9% (11/19), respectively. β-lactams were the most used antibiotics in both periods. Malaria was the most common di...
Information resource commissioned by NHS CFH to support the implementation of ePrescribing within... more Information resource commissioned by NHS CFH to support the implementation of ePrescribing within acute and foundation trusts. Aimed at senior decision makers within trusts, but also colleagues – including practising clinicians – who may be implementing, supporting and/or using ePrescribing systems.
Objectives The medication safety officer (MSO) role was created following a patient safety alert,... more Objectives The medication safety officer (MSO) role was created following a patient safety alert, with an action for MSOs to be active participants in a national network in England, which included regular online webinar meetings and an online forum. The aim of the study was to assess the effectiveness of digital platforms in facilitating interaction and communication by the MSO network. The objectives were to establish the proportion of MSOs who interact through monthly webinars and the online forum. A secondary objective was to identify barriers and facilitators for engaging digitally within the MSO network. Methods An online survey was used alongside semistructured interviews. The online survey was disseminated to all 400 MSOs registered with the UK Department of Health Central Alerting System from December 2018 to February 2019. Interviewees were identified purposively through snowball sampling and voluntarily through the survey. Results 84 MSOs responded to the survey (21% respo...